New Directions in Treatments Targeting Stroke Recovery

Stroke. 2018 Dec;49(12):3107-3114. doi: 10.1161/STROKEAHA.118.021359.

Authors

David J Lin¹, Seth P Finklestein², Steven C Cramer³

Affiliations

¹ From the Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital, Boston (D.J.L.).
² Stroke Service, Department of Neurology, Massachusetts General Hospital, Boston (S.P.F.).
³ Department of Neurology, University of California, Irvine (S.C.C.).

No abstract available

Keywords: brain; clinical trials; rehabilitation; stroke; therapeutics.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Brain-Computer Interfaces
Carbidopa / therapeutic use
Cell- and Tissue-Based Therapy
Chorionic Gonadotropin / therapeutic use
Dopamine Agonists / therapeutic use
Drug Combinations
Epoetin Alfa / therapeutic use
Humans
Levodopa / therapeutic use
Occupational Therapy
Physical Therapy Modalities
Recovery of Function*
Robotics
Selective Serotonin Reuptake Inhibitors / therapeutic use
Speech Therapy
Stroke / therapy*
Stroke Rehabilitation / trends*
Telerehabilitation
Transcranial Direct Current Stimulation
Transcranial Magnetic Stimulation
Vagus Nerve Stimulation
Virtual Reality

Substances

Chorionic Gonadotropin
Dopamine Agonists
Drug Combinations
Serotonin Uptake Inhibitors
carbidopa, levodopa drug combination
Levodopa
Epoetin Alfa
Carbidopa

Grants and funding